Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 1,368.8% in February

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 47,000 shares, a growth of 1,368.8% from the January 31st total of 3,200 shares. Based on an average daily volume of 512,200 shares, the days-to-cover ratio is currently 0.1 days.

Biodexa Pharmaceuticals Price Performance

Shares of Biodexa Pharmaceuticals stock opened at $3.33 on Friday. Biodexa Pharmaceuticals has a 1 year low of $3.18 and a 1 year high of $74.00. The company’s 50 day moving average is $4.23.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.